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ARTICLE
A synthetic metabolic network for physicochemical
homeostasis
Tjeerd Pols1,2, Hendrik R. Sikkema1,2, Bauke F. Gaastra1,2, Jacopo Frallicciardi1, Wojciech M. Śmigiel 1,
Shubham Singh1 & Bert Poolman 1
One of the grand challenges in chemistry is the construction of functional out-of-equilibrium
networks, which are typical of living cells. Building such a system from molecular components
requires control over the formation and degradation of the interacting chemicals and
homeostasis of the internal physical-chemical conditions. The provision and consumption of
ATP lies at the heart of this challenge. Here we report the in vitro construction of a pathway
in vesicles for sustained ATP production that is maintained away from equilibrium by control
of energy dissipation. We maintain a constant level of ATP with varying load on the system.
The pathway enables us to control the transmembrane ﬂuxes of osmolytes and to demon-
strate basic physicochemical homeostasis. Our work demonstrates metabolic energy con-
servation and cell volume regulatory mechanisms in a cell-like system at a level of complexity
minimally needed for life.
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The generation and consumption of ATP lies at the heart oflife. Complex networks of proteins, nucleic acids and smallmolecules sustain the essential processes of gene expression
and cell division that characterize living cells, but without ATP
they are non-functional. Herein lies one of the major challenges
in the construction of synthetic cell-like systems. Other processes,
such as achieving tunable DNA replication, efﬁcient transcription
and translation, and vesicle division1,2 are essentially secondary to
the solution of a controlled energy supply. Metabolic energy
conservation is a prerequisite for synthetic systems no matter how
complex. Energy is critical not just for (macro)molecular synth-
eses but also for maintaining the cytoplasm in a state compatible
with metabolism through control over pH, ionic strength and
solute composition. Here we have addressed that issue and show
that we can control ATP production and ionic homeostasis in
synthetic vesicles.
The bottom-up construction of synthetic cells from mole-
cular components3 differs in concept and strategy from the
top–down approach to engineer minimal cells, pioneered by the
J. Craig Venter institute4. Yet, both approaches address what
tasks a living cell should minimally perform and how this can
be accomplished with a minimal set of components. New bio-
chemical functions and regulatory principles will be discovered
as we make progress toward constructing a minimal cell. In the
ﬁeld of bottom-up synthetic biology (perhaps better called
synthetic biochemistry), work is progressing toward establish-
ing new information storage systems5, replication of DNA by
self-encoded proteins6, the engineering of gene and protein
networks7,8, formation of skeletal-like networks9, biosynthesis
of lipids10–12, division of vesicles13,14, development of non-lipid
compartment systems15,16 and chemical homeostasis through
self-replication17,18. Protein synthesis has been realized using
recombinant elements19, which have been incorporated into
vesicles20,21 or water-in-oil droplets16. However, long-term
sustained synthesis of chemicals is a bottleneck in the devel-
opment and application of synthetic cell-like systems22,23. At
the root of the poor performance of reconstituted systems are
challenges that relate to sustained production of nucleotides,
import of substrate(s) and export of waste product(s), control
of the internal physicochemical conditions (pH, ionic strength,
crowding) and stability of the lipid-bounded compartment, all
of which require constant energy dissipation.
Inspired by the challenges of the bottom-up construction of
a living cell, we focus on the development of new open
vesicle systems that sustain nucleotide levels and electro-
chemical gradients to allow further functionalities to be inte-
grated. ATP is especially crucial, not only as a source of
metabolic energy for most biological processes, but also as a
hydrotrope, inﬂuencing the viscosity and possibly the structure
of the cytosol24. Energy consumption in a growing cell is
dominated by polymerization reactions and maintenance pro-
cesses25, so regeneration of ATP is required to keep the cell
running. Recent developments in the ﬁeld of synthetic bio-
chemistry have started to address the issue of ATP homeostasis.
A cell-free molecular rheostat for control of ATP levels has
been reported, employing two parallel pathways and regulation
by free inorganic phosphate26, but the system has not been
implemented in vesicles. Photosynthetic artiﬁcial organelles
have been constructed that form ATP on the outside of small
vesicles, encapsulated in giant vesicles, allowing optical control
of ATP dependent reactions27,28.
Here, we present the construction of a molecular system
integrated into a cell-like container with control of solute ﬂuxes
and tunable supply of energy to fuel ATP-requiring processes. We
have equipped the vesicles with sensors for online readout of the
internal ATP/ADP ratio and pH, allowing us to conclude that the
system enables long-term metabolic energy conservation and
physicochemical homeostasis.
Results
A system for sustained production of ATP. The conversion of
arginine into ornithine, ammonia plus carbon dioxide yields ATP
in three enzymatic steps (Fig. 1a)29. For sustainable energy con-
servation in a compartmentalized system, the import of substrates
and excretion of products have to be efﬁcient, which can be
achieved by coupling the solute ﬂuxes. The antiporter ArcD2
facilitates the stoichiometric exchange of the substrate arginine for
the product ornithine (Fig. 1b)30, which is important for main-
taining the metabolic network away from equilibrium. The ther-
modynamics of the arginine conversion under standard
conditions are given in Fig. 1c. The equilibrium constant of the
conversion of citrulline plus phosphate into ornithine plus
carbamoyl-phosphate is highly unfavorable, but the overall stan-
dard Gibbs free energy difference (ΔG0) of the breakdown of
arginine is negative. Since the actual ΔG is determined by ΔG0 and
the concentration of the reactants, the antiport reaction favors an
even more negative ΔG by maintaining an out-to-in gradient of
arginine and in-to-out gradient of ornithine (Fig. 1d). We
anticipate that NH3 and CO2 will passively diffuse out of the cell.
Engineering of the metabolic network for ATP. To construct
the system for ATP regeneration, we puriﬁed and characterized
arginine deiminase (ArcA), ornithine transcarbamoylase (ArcB),
carbamate kinase (ArcC1), and the arginine/ornithine antiporter
ArcD2. Their kinetic and molecular properties are summarized in
Fig. 2a. The enzymatic network is enclosed with inorganic
phosphate and Mg-ADP in vesicles composed of synthetic lipids,
while ArcD2 is reconstituted in the membrane. The concentration
and number of reporters, ions and metabolites per vesicle is given
in Table 2. The lipid composition of the vesicles is based on
general requirements for membrane transport (bilayer and non-
bilayer-forming lipids, anionic and zwitterionic lipids), which is
tuned to our needs (see below; ref. 31). The vesicles obtained by
extrusion through 400 and 200 nm ﬁlters have an average radius
of 84 nm (SD= 59 nm; n= 2090) and 64 nm (SD= 39 nm; n=
2092), respectively (Fig. 2b and Supplementary Fig. 1), as esti-
mated from cryo-electron microscopy images. The average
internal volumes of the vesicles center around radii of 226 nm
(SD= 113 nm) and 123 nm (SD= 49 nm), respectively (Fig. 2c).
Although a fraction of the vesicles is multi-lamellar, it is likely
that all layers of the vesicles are active because we reconstitute the
membrane proteins in liposomes prior to the inclusion of the
enzymes, sensors and metabolites (protocol A1). The encapsula-
tion of the luminal components is done by ﬁve freeze-thaw cycles,
which induce content exchange between vesicles and homogenize
the membranes. The vesicles obtained by extrusion through 200
nm ﬁlters are more homogenous in size (Fig. 2b, c) but contain a
smaller number of components (Fig. 2a and Table 2), yet the
performance of the metabolic network is similar in both types of
compartments (see below).
We ﬁrst characterized ArcD2 in lipid vesicles without the
enzymatic network and demonstrated exchange of arginine for
ornithine (Fig. 2d). ArcD2 transports arginine in and ornithine
out in both membrane orientations, which is a property of this
type of secondary transporter. The direction of transport is
determined by the concentration gradients of the amino acids,
not by the orientation of the protein. The arginine/ornithine
antiport reaction is not affected by an imposed membrane
potential (ΔΨ) (Fig. 2d, inset). Surprisingly, we also detect that
ArcD2 exchanges arginine for citrulline, albeit at a much lower
rate than the arginine/ornithine antiport (Fig. 2e). The arginine/
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citrulline antiport is electrogenic (Fig. 2e, inset), which agrees
with arginine (and ornithine) being cationic and citrulline being
neutral at pH 7 (Fig. 1b).
The turnover number (kcat) and equilibrium constant (Keq) of
the enzymes were used to guide the initial design of the pathway,
and the enzymes were incorporated in the vesicles at a copy
number well above the stochastic threshold (Fig. 2a). The ArcD2
protein is reconstituted at a lipid-to-protein ratio of 400:1 (w/w),
yielding on average 62 and 19 antiporters per vesicle with radii of
226 and 123 nm, respectively. Since arginine is imported when a
counter solute is present on the inside, we include L-ornithine in
the vesicles to enable the metabolism of arginine. For readout of
ATP production, we enclosed PercevalHR32, a protein-based
ﬂuorescent reporter of the ATP/ADP ratio (Fig. 3a); the
calibration and characterization of the sensor are shown in
Supplementary Fig. 2. Upon addition of arginine, the vesicles
produce ATP. Thus, after an initial, rapid, increase in the ratio of
the excitation maxima at 500 nm and 430 nm (representing an
increase in ATP/ADP ratio) the ratio unexpectedly declines after
30 min (Fig. 3b, blue trace). The ATP/ADP ratio increases again
and stabilizes (Fig. 3b, black trace) in the presence of the
protonophore carbonyl cyanide-4-(triﬂuoromethoxy) phenylhy-
drazone (FCCP), suggesting that arginine conversion by the
metabolic network changes the internal pH of the vesicles (see
below). The drop in ﬂuorescence signal without FCCP is
explained by the pH-dependent binding of nucleotides to
PercevalHR (Supplementary Fig. 2b and 2c). The decrease in
F500/430 signal suggests that the internal pH is decreasing,
because the ﬂuorescence of PercevalHR increases with increasing
pH (Supplementary Fig. 2b).
We found that, in the initial design of the pathway, a
substantial amount of citrulline is formed on the outside, which
is due to residual binding of ArcA to the outer membrane surface
even after repeated washing of the vesicles; control experiments
rule out that ArcA is binding to ArcD2 or OpuA or due to a high
or low concentration of anionic lipid. We thus inactivated
external ArcA by treatment of the vesicles with the membrane-
impermeable sulfhydryl reagent p-chloromercuribenzene sulfo-
nate (pCMBS). To avoid inhibition of the antiporter ArcD2, we
engineered a cysteine-less variant that is fully functional and
insensitive to sulfhydryl reagents (Supplementary Fig. 3). This
optimized system is used for further characterization and
application.
Arginine breakdown and control of futile hydrolysis and pH.
The breakdown of arginine, in the lumen of the vesicle, is given
by the reaction equation:
L-ArginineþH2OþHPO24 þMg-ADP1
þ3Hþ ! L-OrnithineþMg-ATP2 þ 2NHþ4 þ CO2
ð1Þ
The external pH increases upon the addition of arginine
(Fig. 3c), which is in accordance with Eq. (1) when the reaction
products (except for ATP) end up in the outside medium
(Fig. 3d). Unexpectedly, the vesicle lumen acidiﬁes over longer
























































































Fig. 1 Layout and thermodynamics of the system. a Schematic representation of the arginine breakdown pathway. b Structures of arginine, citrulline and
ornithine at neutral pH. c Thermodynamics of arginine conversion for the reactions of ArcA, ArcB, and ArcC1. G0 values were calculated for pH 7.0 and an
ionic strength of 0.1 M using eQuilibrator 2.2. d Thermodynamics of the arginine/ornithine antiport reaction. G values were calculated at varying
concentration gradients of arginine (outside to inside) and ornithine (inside to outside). When the arginine and ornithine gradients are opposite, that is,
[Arg]in < [Arg]out and [Orn]in > [Orn]out, then a negative (and thus favorable) G value is obtained. Four scenarios for the product of the arginine and
ornithine gradients are indicated
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(Fig. 2e, blue line; pyranine calibration shown in Supplementary
Fig. 4); the transient in the internal pH is more evident when the
internal buffer capacity is decreased (Fig. 2e, black line). The
acidiﬁcation of the vesicle lumen cannot be readily explained if
arginine is solely converted into ornithine (Eq. (1)). Indeed, we
found citrulline as an end product in addition to ornithine
(Fig. 4a).
What is the basis for the futile hydrolysis of arginine? Since
external ArcA was inactivated by pCMBS, we infer that part of
the citrulline is not metabolized further but exported and
accompanied by diffusion of NH3 through the membrane. This
side reaction is possible if steps in the pathway downstream of
ArcA are limiting the breakdown of arginine (Fig. 4b, bold arrow)
and when citrulline is exchanged for arginine (Fig. 4b, dashed
arrow). In the vesicles with the full arginine breakdown pathway,
citrulline will compete with ornithine for export, when the
internal citrulline concentration is high. The equilibrium constant
of the reaction catalyzed by ArcB (Keq= 8.5 × 10−6, see Fig. 2a)
predicts high citrulline-to-ornithine ratios in the vesicles. Indeed,
we ﬁnd that the internal citrulline-to-ornithine ratio increases
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Fig. 2 Characterization of the components of the system. aMolecular and kinetic properties of the enzymes; Keq was calculated as in Fig. 1c. The KM values
of a given substrate were determined under conditions of excess of the other substrate. The number of molecules per vesicle was calculated from the
internal concentration of the enzymes and the average size of the vesicles, for 400 nm (left column) and 200 nm (right column) extruded vesicles. Kinetic
parameters of ArcB are given for the back reaction. The kinetic parameters of ArcD2 were estimated from measurements in cells48, assuming that ArcD2
constitutes 1% of membrane protein; the data for OpuA are from ref. 40. b Distribution of the radius of lipid vesicles extruded through a 400 nm (blue bars)
and 200 nm (black bars) polycarbonate ﬁlter as estimated from CryoTEM micrographs (Supplementary Fig. 1). The diameter of 2090 vesicles (400 nm
ﬁlter) and 2092 vesicles (200 nm ﬁlter) were measured using ImageJ. c Distribution of the internal volume, based on the distribution of radii, assuming
that all vesicles are spherical. d Kinetics of arginine uptake in proteoliposomes with 1 mM (blue circles) and 0.1 mM (black squares) ornithine on the inside
(protocol B2); 14C-arginine concentration of 10 µM. Inset: inﬂuence of a membrane potential (ΔΨ) on arginine uptake with 1 mM ornithine on the inside.
Data from replicate experiments (n= 2) are shown, error bars indicate standard deviation. e Kinetics of arginine uptake in proteoliposomes with 10mM
(blue circles) and 1 mM (black squares) citrulline on the inside (protocol B2); 14C-arginine concentration of 10 µM. Inset: inﬂuence of a membrane potential
(ΔΨ) on arginine uptake with 10 mM citrulline on the inside (n= 2). Source data of are provided as a Source Data ﬁle
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from 0 to more than 10 when arginine is converted for 1 h. Thus,
the Keq values of the reactions of citrulline formation and
breakdown (Fig. 2a), and the substrate promiscuity of ArcD2
(Fig. 2d, e) enable arginine/citrulline in addition to arginine/
ornithine antiport.
How do the side reactions of the arginine breakdown pathway
lead to acidiﬁcation of the vesicle lumen? The pKA of NH4+↔
NH3+H+ is 9.09 at 30 °C33, and thus at pH 7.0 the fraction of
NH3 is small, but the base/conjugated acid reaction is fast. If NH3
diffuses across the membrane, it will leave a proton behind in the
vesicle lumen. Since the external volume is large compared with
the internal one, there will be a net ﬂux of NH3 from the vesicle
lumen to the medium. Using stopped-ﬂow ﬂuorescence-based
ﬂux measurements to probe the permeability of the vesicles for
small molecules, we conﬁrmed that NH3 diffuses out rapidly, but
that the membrane is highly impermeable for inorganic
phosphate, K+, and Cl− ions (Fig. 4c). CO2 also diffuses rapidly
across the membrane, down its concentration gradient, but only
NH3 leaves behind protons, therefore it is this that causes the pH
change in the vesicle lumen. Finally, the breakdown of arginine to
ornithine plus NH4+ and CO2 is a dead-end process, which
reaches equilibrium if the produced ATP is not utilized; the
system runs out of ADP in about 30 min. The production of
NH4+ from the conversion of arginine to citrulline then takes
over, and the accompanying diffusion of NH3 out of the vesicles
leads to a net acidiﬁcation of the vesicle lumen (Fig. 4d). Indeed,
in Fig. 4d we show that the vesicles acidify signiﬁcantly less when
the vesicles are loaded with a higher concentration of ADP and
the ATP synthesis is extended.
Load on the metabolic network. Cell growth is impacted by the
solute concentration of the environment. Control of osmolyte
import and export under conditions of osmotic stress allows cells
to maintain their volume and achieve physicochemical home-
ostasis34–36. Potassium is the most abundant osmolyte in many
(micro)organisms, but excessive salt accumulation increases the
ionic strength, which diminishes enzyme function. To control
the volume, internal pH, and ionic strength, bacteria modulate
the intake of potassium ions. When needed, they replace the
electrolyte for so-called compatible solutes, like glycine betaine,
proline and/or sugars37. Compatible solutes like glycine betaine
not only act in volume regulation but also prevent aggregation of
macromolecules by affecting protein folding and stability38,39.
The energy produced by the ATP breakdown pathway has been
used to modulate the balance of osmolytes in the vesicles via
activating the ATP-driven glycine betaine transporter OpuA
(Fig. 4e). To this end we co-reconstituted OpuA with the
components of the metabolic network for ATP production. OpuA
transports solutes into the vesicle lumen when the protein is
oriented with the nucleotide-binding domains on the inside. It
happens to be that we reconstitute OpuA for more than 90% in
this desired orientation31,40, but any protein in the opposite
orientation is non-functional because ATP is only produced
inside the vesicles. In vesicles with 13 mol% DOPG [1,2-di-(9Z-
octadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol)] OpuA is
constitutively active and imports glycine betaine at the expense of
ATP (Fig. 5a), albeit at a low rate41. OpuA is ionic strength-gated
and more active when sufﬁcient levels of anionic lipids are
present in the membrane31,41, which is the physiologically more
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Fig. 3 Generation of ATP and pH changes. The internal composition of the vesicles at the start of the experiment is given in Fig. 2a (enzymes) and Table 2
(ions, metabolites) and the preparation of vesicles is given in protocol A1, unless speciﬁed otherwise. a Schematic representation of PercevalHR;
modiﬁcation of cartoon in ref. 32. b Effect of FCCP on the ﬂuorescence readout of PercevalHR (protocol A1); the ratio of the ﬂuorescence peaks at 500 nm
and 430 nm is shown. In the absence of FCCP, the ﬂuorescence readout declines 30min after addition of 10mM arginine (at t= 0) due to changes in the
internal pH (addition of FCCP after 2 h increases the signal, indicated by the black arrow). The ﬂuorescence signal is constant for several hours in the
presence of 10 µM FCCP (n= 2). c External pH change (protocol B5) of arginine-metabolizing vesicles in outside medium with 10mM KPi pH 7.0 plus
355mM KCl. The ATP production was started by adding 5mM arginine at t= 0. d Schematic representation of the pH effects caused by ammonia and
carbon dioxide diffusion. e Internal pH change (protocol B4) of arginine-metabolizing vesicles with either 50mM (blue trace) or 15 mM KPi plus 40mM
KCl, pH 7.0 on the inside (protocol A2; black trace). Five millimolar arginine was added at t= 0 (n= 2)
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relevant situation; for this, we use 38 mol% DOPG and an
internal ionic strength below 0.2M to lock OpuA in the off state.
By increasing the medium osmolality with membrane-
impermeant osmolytes (KPi or KCl), the vesicles shrink due to
water efﬂux (Fig. 5b) until the internal osmotic balance is
achieved, which occurs on the timescale of <1 s. Thus, the
pressure exerted by the addition of KPi or KCl is dissipated by
lowering the volume-to-surface ratio of the vesicles. The
accompanying increase in internal ionic strength activates OpuA
and glycine betaine is imported to high levels (Fig. 5c, blue
circles). The vesicles now possess an interior that is a mixture of
glycine betaine and salts. The consumption of ATP by the gated
import of glycine betaine is shown in Fig. 6a. Most remarkably,
the gated import continues for hours when the internal ionic
strength remains above the gating threshold and the pH is kept
constant (Fig. 5c, blue circles). The open system, with arginine
feed and product drain, performs at least an order of magnitude




























































































Fig. 4 Control of futile hydrolysis of arginine and pH homeostasis. The internal composition of the vesicles at the start of the experiment is given in Fig. 2a
(enzymes) and Table 2 (ions, metabolites) and the preparation of vesicles is given in protocol A1, unless speciﬁed otherwise. a External concentration of
metabolites (protocol B6): arginine (blue circles), citrulline (pink triangles), ornithine (yellow diamonds), and NH3 (black squares), as measured by HPLC in
vesicles treated with 25 µM pCMBS. Five millimolar arginine was added at t= 0. b Schematic representation of arginine breakdown; the futile hydrolysis of
arginine and arginine/citrulline exchange are depicted by bold and dashed arrows, respectively. c Stopped-ﬂow ﬂuorescence measurements to determine
the permeability of the vesicles for NH4Cl (blue trace), NH4-acetate (black trace), potassium phosphate (pink trace) and sodium acetate (yellow trace);
pyranine inside the vesicles was used as pH indicator (n≥ 2). d Internal pH change (protocol B4) of arginine-metabolizing vesicles with either 5 mM Mg-
ADP (protocol A1; blue trace) or 15 mM Mg-ADP on the inside (protocol A3; black trace). Five millimolar arginine was added at t= 0 (n= 2). e Homology
model of OpuA and structure of the compatible solute glycine betaine. Glycine betaine import via OpuA consumes the ATP as indicated in (b)
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Fig. 5 ATP/ADP homeostasis and long-term transport. The internal composition of the vesicles at the start of the experiment is given in Fig. 2a (enzymes)
and Table 2 (ions, metabolites) and the preparation of vesicles is given in protocol A1, unless speciﬁed otherwise. a Effect of external glycine betaine (GB)
on the ATP/ADP ratio measured by PercevalHR (protocol B3) in unshocked arginine-metabolizing vesicles (made with 13 mol% of DOPG; protocol A7), in
the presence (black trace) and absence (blue trace) of 180 µM glycine betaine, added at t=−0.5 h. Five millimolar arginine was added at t= 0 (n= 2).
b Schematic representation of the effect of osmotic upshift and partial volume restoration through glycine betaine uptake are shown. c Comparison of
glycine betaine uptake (protocol B1) driven by ATP formed in the arginine breakdown pathway from 400 nm extruded vesicles (blue circles), 200 nm
extruded vesicles (protocol A4; black squares), and the creatine-phosphate/kinase system (protocol A5; pink triangles) (n= 2)
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substrate for ATP synthesis is present on the inside and cannot
be replenished, as exempliﬁed by the creatine-phosphate/kinase
system (Fig. 5c, pink triangles)40. Comparable results were
obtained when smaller, yet more homogenous vesicles were
formed by extrusion through 200 nm polycarbonate ﬁlters
(Fig. 5c, black squares, see also Supplementary Fig. 5).
To determine the fraction of vesicles with a fully functional
arginine breakdown pathway, we compared the rates of transport
of glycine betaine in our synthetic cell system with those of OpuA
vesicles containing 10 mM of ATP. With our synthetic network
transport only occurs when ATP is formed, which requires the
presence of each of the enzymes well above the stochastic
threshold. When the metabolic pathway reaches steady state, the
ATP and ADP concentrations are about 3.3 and 1.7 mM,
respectively (see Table 2, ATP/ADP ratio of 2), and under these
conditions we determined the rate of transport via OpuA. The KM
value for ATP is 3 mM and the KI for ADP is 12 mM (taken from
ref. 42). From these numbers we compute the V/VMAX for
transport in the synthetic vesicles. For the OpuA vesicles with
10 mM ATP there is negligible formation of ADP when initial
rates of transport are determined, and the V/VMAX is calculated
similarly. From the ratio of the V/VMAX in the vesicles with full
pathway over the V/VMAX in the OpuA vesicles (Fig. 5c), we
obtain a lower limit for the fraction of active vesicles of 70%.
Physicochemical homeostasis. Next, we tested how the physi-
cochemical homeostasis is sustained when the vesicles are
osmotically challenged. Figure 6a shows the evolution in time of
the ATP/ADP ratio upon addition of arginine to vesicles that
were exposed to an increased medium osmolality 30 min before
the addition of arginine; FCCP was added to avoid pH effects on
the readout of PercevalHR (Supplementary Fig. 2b). In the
absence of glycine betaine the ATP/ADP ratio peaks at 1 h and
decreases over the next 4–5 h (Fig. 6a, blue line), which indicates
the presence of futile ATP hydrolysis when the internal salt
concentration is high. Intriguingly, when glycine betaine was
added 0.5 h after arginine (Fig. 6a, black line), the ATP/ADP ratio
drops instantly, but then remains stable for 6 h. Glycine betaine
therefore has two effects: its accumulation provides a ‘cytosol’
that is more compatible with enzyme function (Fig. 6b, c), but it
also provides a metabolic sink for ATP through its OpuA-
mediated transport. The decrease in ATP/ADP ratio in the
absence of glycine betaine can be explained by inhibition of






































































































Fig. 6 Physicochemical homeostasis of arginine-metabolizing vesicles. The internal composition of the vesicles at the start of the experiment is given in
Fig. 2a (enzymes) and Table 2 (ions, metabolites) and the preparation of vesicles is given in protocol A1, unless speciﬁed otherwise. a Effect of glycine
betaine (GB) on the ATP/ADP ratio measured by PercevalHR (protocol B3) inside arginine-metabolizing vesicles exposed to an osmotic upshift (addition
of 250mM KCl externally) in the presence (black trace) and absence (blue trace) of 180 µM glycine betaine, added at t= 0.5 h. Five millimolar arginine
was added at t= 0 (n= 3). b Activity of ArcA (left), ArcB (middle), and ArcC1 (right) in 50mM KPi, pH 7.0 (black bar), and 300mM KPi, pH 7.0 (blue
bar) as determined from the production of citrulline (ArcA, ArcB) or ATP (ArcC1). The activities were normalized to those in 50mM KPi, pH 7.0, the
absolute activities are given in Supplementary Table 3; error bars indicate standard deviation (n= 2). c Stability of ArcA (top), ArcB (middle), and ArcC1
(bottom) in 50mM KPi, pH 7.0 (left), and 300mM KPi, pH 7.0 (right) at 30 °C, in the presence (black squares) and absence (blue circles) of 200mM
glycine betaine (n= 2). d Effect of glycine betaine on the internal pH measured by pyranine (protocol B4) inside arginine-metabolizing vesicles exposed
to an osmotic upshift (250mM KCl) in the presence (black trace) and absence (blue trace) of 180 µM glycine betaine, added at t= 0.5 h. Five millimolar
arginine was added at t= 0 (n= 3). e Schematic representation of the synthetic metabolic network in the cell-like container with the intermediates:
arginine (red squares), ornithine (blue circles), citrulline (orange triangles), carbamoyl-phosphate (pink triangles), and glycine betaine (yellow ovals). NH3
and CO2 are not shown. Source data of are provided as a Source Data ﬁle
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futile hydrolysis of ATP. Accordingly, the decrease in ATP/ADP
ratio is much less in vesicles in which the ionic strength is kept
low (Fig. 5a); compare Figs. 5a and 6a. Finally, we report ATP/
ADP ratios because the absolute concentrations change when the
vesicles are osmotically shrunk and subsequently regain volume.
In most experiments, the initial adenine nucleotide (=ADP)
concentration was 5 mM but increases when the vesicles are
exposed to osmotic stress. In Fig. 5a, we report data of unshocked
vesicles and here the ATP/ADP ratios of 2–3 correspond to
3.33–3.75 mM of ATP, respectively, which is in the range of
concentrations in living cells.
Importantly, the introduction of an ATP-consuming process
stimulates the full pathway at the expense of citrulline formation,
and hence should stabilize the internal pH. Indeed, our results
show that the system is better capable of maintaining the internal
pH relatively constant when ATP is utilized (Fig. 6d, black line).
Under these conditions the arginine-to-citrulline conversion is
diminished relative to full pathway activity. We therefore propose
that the stabilizing effect of glycine betaine accumulation
originates from a lowering of the ionic strength (partial
restoration of the vesicle volume), a chaperoning effect on the
proteins and the maintenance of the internal pH, hence reﬂecting
what compatible solutes do in living cells37.
In summary and perspective: we present the in vitro construc-
tion of a cell-like system that maintains a metabolic state far-
from-equilibrium for many hours (Fig. 6e). This is one of the
most advanced functional reconstitutions of a chemically deﬁned
network ever achieved, which allows the development of complex
life-like systems with adaptive behavior in terms of lipid and
protein synthesis, cell growth and intercellular communication.
We show that ATP is used to fuel the gated transport of glycine
betaine, which allows the synthetic vesicles to maintain a basic
level of physicochemical homeostasis. We have recently postu-
lated alternative mechanisms for metabolic energy conservation43
by coupling substrate/product antiporters to substrate decarbox-
ylation, allowing the formation of a proton or sodium motive
force. Combining such a pathway with the here-developed
network for ATP would allow an even greater control of the
physicochemical homeostasis.
Maintenance of the ATP/ADP ratio, internal pH, and
presumably ionic strength are crucial for any metabolic system
in the emerging ﬁeld of synthetic biochemistry23,26. We expect
that our metabolic network will ﬁnd wide use beyond membrane
and synthetic biology, as biomolecular out-of-equilibrium
systems will impact the development of next generation materials
(e.g. delivery systems) with active, adaptive, autonomous, and
intelligent behavior.
Methods
Materials. Common chemicals were of analytical grade and ordered from Sigma-
Aldrich Corporation, Carl Roth GmbH & Co. KG or Merck KGaA. The lipids were
obtained from Avanti Polar Lipids, Inc. (> 99% pure, in chloroform): 1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine (DOPE) [850725C], 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) [850375C], and 1,2-dioleoyl-sn-glycero-3-phospho-(1′-
rac-glycerol) (DOPG) [840475C]. n-dodecyl-β-D-maltoside (DDM) [D97002] was
purchased from Glycon Biochemicals GmbH and Triton X-100 [T9284] from
Sigma-Aldrich Corporation. 14C-glycine betaine was prepared enzymatically from
14C-choline-chloride (American Radiolabeled Chemicals, Inc. [ARC 0208, 55 mCi
mmol−1]) as described in ref. 31. 14C-arginine was purchased from Moravek, Inc.
[MC-137, 338 mCi mmol−1], 14C-citrulline from American Radiolabeled Chemi-
cals, Inc. [ARC 0508, 55 mCi mmol−1], and 3H-ornithine hydrochloride from
PerkinElmer Health Sciences, Inc. [NET1212, 21.4 Ci mmol−1].
Construction of expression strains. The arcX genes were PCR-ampliﬁed from the
genome of Lactococcus lactis IL1403 with primers arcX-Fw and arcX-rev (see
Supplementary Table 1), using Phusion HF DNA polymerase (Thermo Fisher
Scientiﬁc, Inc.). The arcA and arcB PCR inserts, and the pNZcLICoppA vector44,
were digested with NcoI and BamHI and subsequently ligated to yield pNZarcA
and pNZarcB. These vectors contain the corresponding genes under the control of
the nisin-inducible PNIS promoter45 and the genes have a cleavable 6His-tag at the
N-terminus.
The arcC1 and arcD2 PCR inserts were used for ligation-independent cloning as
described in ref. 46. This yielded pNZarcC1 and pNZarcD2 with the genes under
the control of the PNIS promoter and with a cleavable 10His-tag at the N- and C-
terminus, respectively. To construct the cysteine-less variant of arcD2 (arcD2ΔC),
two mutations were made, namely C395T and C487T. The arcD2 gene was PCR-
ampliﬁed from pNZarcD2 with uracil-containing primers (arcD2ΔC-X), using
PfuX7 DNA polymerase47. The two ampliﬁed fragments were ligated with USER
enzyme (New England Biolabs, Inc.) to create the pNZarcD2ΔC vector.
The pNZarcA, pNZarcB, and pNZarcC1 vectors were transformed into L. lactis
NZ900045, while pNZarcD2 and pNZarcD2ΔC were transformed into L. lactis
JP9000 ΔarcD1D248 (Supplementary Table 2). The pRsetB-PercevalHR plasmid
was a gift from professor Gary Yellen (Addgene plasmid #49081, ref. 32) and
transformed into E. coli BL21-DE3 (Supplementary Table 2).
Expression of genes. L. lactis cells were grown in rich medium [2% (w/v) Gistex
from Brenntag AG], 65 mM NaPi, pH 7.0, 1% (w/v) glucose) with 5 µg mL−1
chloramphenicol at 30 °C with stirring (200 rpm). The strains for ArcA, ArcB, and
ArcC1 production were grown as 3 L cultures in 5 L ﬂasks and induced at an
optical density at 600 nm (OD600) of 0.5 with 0.05% (v/v) of culture supernatant
from a nisin A-producing strain45. In contrast, the strains for ArcD2 and OpuA
were grown as 2 L cultures in a 3 L bioreactor stirred at 200 rpm with pH control
(kept above pH 6.5 with 4M KOH) and induced at an OD600 of 2.0 with 0.05%
(v/v) of culture supernatant from a nisin A-producing strain. After induction, all
strains were grown for an additional 2 h before harvesting. Harvesting and washing
was done by centrifugation (15 min, 6000 × g, 4 °C) and resuspension of the cells in
ice-cold 100 mM KPi, pH 7.0 (buffer A, Table 1). Finally, cells were centrifuged
again and resuspended to an OD600 of 100 in ice-cold 50 mM KPi, pH 7.0 (buffer
B), ﬂash-frozen in liquid nitrogen in aliquots of 50 mL and stored at −80 °C.
Preparation of cell lysates and membrane vesicles. The preparation of cell
lysate and membrane vesicles was done as follows. After cells were thawed on ice,
100 µg mL−1 DNAse and 2 mM MgSO4 were added. Cells were lysed by high-
pressure disruption (Constant Systems, Ltd.) with two passages at 39 kpsi and 4 °C.
After lysis, 5 mM Na2-EDTA (pH 8.0) and 1 mM PMSF (100 mM stock in iso-
propanol) were added and cell debris was removed by centrifugation (15 min,
22,000 × g, 4 °C). Next, the supernatant was centrifuged for 90 min at 125,000 × g at
4 °C. For ArcA, ArcB, and ArcC1, the supernatant (containing cell lysate) was
ﬂash-frozen in liquid nitrogen in 10 mL aliquots and stored at −80 °C. For ArcD2
and OpuA, the pellets (containing membrane vesicles) were resuspended in ice-
cold buffer B [with 20% (v/v) glycerol for OpuA], to a 10 mgmL−1 protein con-
centration before ﬂash-freezing (2 mL aliquots) and storage.
E. coli BL21-DE3 pRsetB-PercHR cells were grown in lysogeny broth (LB) with
100 µg mL−1 ampicillin. In total, 0.5 L cultures were grown in 5 L ﬂasks at 30 °C
with shaking (200 rpm) to an OD600 of 0.7, after which they were cooled to 22 °C,
induced with 100 µM isopropyl β-D-1-thiogalactopyranoside (IPTG) and grown
for an additional 72 h before harvesting as described in ref. 32. Harvesting and
washing was done by centrifugation (15 min, 6000 × g, 4 °C) and resuspension in
ice-cold 50 mM NaPi, pH 7.0 with 100 mM NaCl. Finally, cells were centrifuged
again and resuspended to an OD600 of 100 in ice-cold 20 mM NaPi, pH 7.0
with 100 mM NaCl, ﬂash-frozen in liquid nitrogen in 50 mL aliquots and stored at
−80 °C. Cell lysate was prepared by adding 250 µg of DNAse to thawed cells, after
which they were lysed by high-pressure disruption in a single passage at 25 kpsi
and 4 °C. After lysis, 0.1 mM PMSF was added and cell debris was removed by
centrifugation for 60 min at 145,000 × g at 4 °C. The supernatant (containing cell
lysate) was ﬂash-frozen in liquid nitrogen in 15 mL aliquots and stored at −80 °C.
Puriﬁcation of ArcA, ArcB, and ArcC1. All protein puriﬁcation and handling steps
were performed on ice or at 4 °C, except when speciﬁed otherwise. Ni2+-Sepharose
resin was pre-equilibrated in 50 mM KPi, pH 7.0, with 200 mM NaCl (buffer C)
with either 10 mM imidazole for ArcA and ArcB or 5 mM imidazole and 10% (v/v)
glycerol for ArcC1. Cell lysate was thawed on ice, added to the Ni2+-Sepharose
Table 1 Buffers used in this study
Buffer Composition
A 100mM KPi, pH 7.0
B 50mM KPi, pH 7.0
C 50mM KPi, pH 7.0 with 200mM NaCl
D 50mM KPi, pH 7.0 with 100mM NaCl
E 25mM KPi, pH 8.0 with 500mM NaCl plus 5% (v/v) glycerol
F 50mM KPi, pH 7.0 with 200mM KCl
G 100mM KPi, pH 7.0 with 0.5 mM ornithine
H 50mM NaPi, pH 7.0
I 100mM KPi, pH 7.0 with 250mM KCl
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resin (0.5 mL bed volume per 10 mg total protein) and nutated for 1 h. The mixture
was poured over a poly-prep column (Bio-Rad Laboratories, Inc.), after which the
resin was washed with 20 column volumes of buffer C with 50 mM imidazole [plus
10% (v/v) glycerol for ArcC1]. Proteins were then eluted with three column
volumes of buffer C with 500 mM imidazole [plus 10% (v/v) glycerol for ArcC1].
The most concentrated fractions were run on a Superdex 200 Increase 10/300 GL
size-exclusion column (GE Healthcare) in 50 mM KPi, pH 7.0 with 100 mM NaCl
(buffer D) [plus 10% (v/v) glycerol for ArcC1]. Protein containing fractions were
pooled and concentrated to 4–5 mgmL−1 in a Vivaspin 500 (30,000 kDa) cen-
trifugal concentrator (Sartorius AG), after which they were aliquoted, ﬂash-frozen
in 100 µL aliquots and stored at −80 °C.
In addition, ArcA, ArcB, and ArcC1 have been puriﬁed in 50 mM NaPi, pH 7.0
instead of 50 mM KPi pH 7.0 to allow reconstitutions devoid of potassium ions
(protocol A6, see below); the system is also fully functional in sodium ion-based
buffers.
Puriﬁcation of PercevalHR. PercevalHR was puriﬁed in a manner similar to ArcA,
ArcB, and ArcC1, except that different buffers were used. Ni2+-Sepharose resin was
pre-equilibrated in 25 mM KPi buffer, pH 8.0 with 500 mM NaCl with 5% (v/v)
glycerol (buffer E) plus 10 mM imidazole. The resin was washed with buffer E plus
25 mM imidazole and protein was eluted with buffer E plus 250 mM imidazole.
The most concentrated fractions were run on a Superdex 200 Increase 10/300 GL
size-exclusion column (GE Healthcare) in 10 mM NaPi, pH 7.4 with 150 mM NaCl
and 5% (v/v) glycerol. Protein containing fractions (1–2 mgmL−1) were aliquoted
in volumes of 50 µL, ﬂash-frozen and stored at −80 °C.
Enzymatic assays for ArcA and ArcB. Activity of ArcA and ArcB was measured
with the COLDER assay49. In brief, either 2 µg mL−1 ArcA, or 0.25 µg mL−1 ArcB
was incubated in buffer B at 30 °C for 3 min, in a total volume of 275 µL. To start
the reaction, varying concentrations of either L-arginine for ArcA (0–480 µM L-
arginine), or L-ornithine plus carbamoyl-phosphate for ArcB (0–10 mM L-
ornithine plus 0–10 mM carbamoyl-phosphate) were added. Two hundred
microliters of COLDER solution (20 mM 2,3-butanedione monoxime, 0.5 mM
thiosemicarbazide, 2.25 M phosphoric acid, 4.5 M sulfuric acid and 1.5 mM
ammonium iron(III) sulfate) was pipetted into each well of a 96-well ﬂat-bottom
transparent polystyrene plate (Greiner Bio-One International GmbH), to which
50 µL of reaction mixture was added at given time intervals to stop the enzymatic
conversion. In addition, a set of calibration samples with citrulline concentrations
from 0 to 250 µM was added into the wells in the plate. To allow color develop-
ment, the plate was sealed with thermo resistant tape (Nalge Nunc International)
and incubated at 80 °C for 20 min in a block heater (Stuart). Afterward, the plate
was cooled down to room temperature for 30 min, the condensate was centrifuged
(1 min, 1000 × g, 20 °C) and the absorbance of the solutions in the wells was
measured at 540 nm in a platereader (BioTek Instruments, Inc.). Enzyme activity







where Δenz and Δcal are the slopes of the enzyme and calibration curves,
respectively, in AUmin−1 and AU nmol−1 citrulline; Cenz is the ﬁnal concentration
of enzyme in mgmL−1 and Volrmx is the volume of the reaction mixture in mL.
Stability measurements of ArcA and ArcB were performed as described above,
with minor adjustments. In brief, ArcA and ArcB were diluted in either buffer B or
300 mM KPi, pH 7.0, with and without 200 mM glycine betaine, and incubated at
30 °C for 0, 1, 3, and 5 h. To start the reaction, either 150 µM arginine (for ArcA) or
5 mM carbamoyl-phosphate plus 5 mM citrulline (for ArcB) were added.
Enzymatic assays for ArcC1. The activity of ArcC1 was measured from changes in
ATP/ADP ratio with PercevalHR. In all, 3.3 µg mL−1 ArcC1 was incubated in
buffer B supplemented with 5 mM of MgSO4 and 10 µg mL−1 of puriﬁed Perce-
valHR in 105.250-QS cuvettes (Hellma Analytics) in a FP-8300 spectroﬂuorometer
(Jasco, Inc.). ADP was added in varying concentrations (0.1–10 mM) and the
mixture was incubated at 30 °C for 5 min. To start the reaction, carbamoyl-
phosphate was added in varying concentrations (0.2–10 mM). The ﬂuorescence
spectrum of PercevalHR was measured by excitation from 400 ± 5 to 510 ± 5 nm,
while the emission was recorded at 550 ± 5 nm. As the pH of the reaction mixture
changes in time and PercevalHR is sensitive to pH, it was necessary to measure the
pH changes and correct the PercevalHR readout accordingly. In the pH experi-
ments PercevalHR was substituted with 0.1 µM pyranine and the ﬂuorescence
spectrum of pyranine was measured by excitation from 380 ± 5 to 480 ± 5 nm,
while the emission was recorded at 512 ± 5 nm. Pyranine was calibrated as
described under internal pH measurements with pyranine (see below).
The PercevalHR signal was calibrated at a sensor concentration of 10 µg mL−1
in buffer B with varying pH values (from 6.6 to 7.6), containing a mixture of ATP
and ADP at a total concentration of 5 mM and a total MgSO4 concentration of
5 mM. The ATP/ADP ratio was plotted against the ratio of the two excitation peaks
at 430 and 500 nm and were ﬁtted using the Hill equation:
F500nm
F430nm






where k is the apparent afﬁnity constant; n is the Hill coefﬁcient; start and end refer
to the y-values at the vertical asymptotes. The Hill coefﬁcient was constrained to 1.
When the parameters of datasets recorded at varying pH values were compared, it
was evident that only start and end were affected by pH, k remained constant. The
start and end values were plotted against the pH and were ﬁtted by using the
following logistic equations (Supplementary Fig. 2c):
start ¼ y0 þ A ´ eR0 ´ pH; end ¼ y0 þ A ´ eR0 ´ pH ð4Þ
where y0, A, and R0 are the ﬁt parameters. The resulting equations were
incorporated into Eq. (3) to yield a formula in which the ATP/ADP ratio is
dependent on the pH of the solution and the ratio of the excitation peaks at 430





F430nm  0:021þ 2 ´ 106 ´ e1:76 ´ pHð Þ
 
1:15þ 3:5 ´ 103 ´ e0:96 ´ pHð Þ  F500nmF430nm
ð5Þ
Stability measurements of ArcC1 were performed as described above, with
minor adjustments. In brief, ArcC1 was diluted in buffer B or 300 mM KPi, pH 7.0,
with and without 200 mM glycine betaine, and incubated at 30 °C for 0, 1, 3 and
5 h. After incubation, 5 mM of ADP, 5 mM of MgSO4 and either PercevalHR or
pyranine were added. After 5 min of incubation at 30 °C, the reaction was started
with the addition of 5 mM of carbamoyl-phosphate. For the experiments
performed in 300 mM KPi pH 7.0 a new calibration of both PercevalHR and





F430nm 0:214þ 8:2 ´ 105 ´ e1:29 ´ pHð Þ
 
0:52þ 6:3 ´ 104 ´ e1:15 ´ pHð Þ  F500nmF430nm
ð6Þ
Puriﬁcation of ArcD2 and OpuA. Membrane vesicles were quickly thawed and
diluted to a total protein concentration of 3 mgmL−1 for OpuA and 7 mgmL−1 for
ArcD2 in 50 mM KPi, pH 7.0 plus 200 mM KCl (buffer F) containing 20% (v/v)
glycerol in case of OpuA. 0.5% (w/v) n-dodecyl-β-D-maltoside (DDM) was added
to the vesicles for solubilization and the mixture was nutated for either 30 min
(ArcD2) or 60 min (OpuA). Unsolubilized material was removed by centrifugation
(20 min, 270,000 × g, 4 °C). Ni2+-Sepharose resin (0.5 mL of Ni2+-Sepharose resin
per 20 mg total protein for OpuA or 0.25 mL of Ni2+-Sepharose resin per 10 mg
total protein for ArcD2) was pre-equilibrated in buffer F with 10 mM imidazole
plus 0.03% (w/v) DDM. The supernatant was diluted 1.6× fold (ArcD2) or 2.5× fold
(OpuA) to reduce the DDM concentration and then added to the Ni2+-Sepharose
column material and nutated for 1 h at 4 °C. The mixture was poured into a poly-
prep column, after which the resin was washed with 20 column volumes of
buffer F containing 50 mM imidazole plus 0.02% (w/v) DDM and 20% (v/v) gly-
cerol in case of OpuA. Proteins were eluted in 3 column volumes of buffer F
with 500 mM imidazole plus 0.02% (w/v) DDM and 20% (v/v) glycerol in case
of OpuA.
Light scattering for oligomeric state determination. Ni2+-Sepharose/size-
exclusion chromatography-puriﬁed fractions of ArcA, ArcB, ArcC, and ArcD2
were analyzed on a second Superdex 200 Increase 10/300 GL size-exclusion column
(GE Healthcare) in buffer D [with 0.02% (w/v) DDM for ArcD2], which was
coupled to a multi-angle light scattering system with detectors for absorbance at
280 nm (Agilent Technologies, Inc.), static light scattering (Wyatt Technology
Corporation) and differential refractive index (Wyatt Technology Corporation).
Data analysis was performed with the ASTRA software package (Wyatt Technology
Corporation), using a value for the refractive index increment (dn/dc)protein of
0.180 mLmg−1 and (dn/dc)detergent of 0.143 mLmg−1 50.
Co-reconstitution of ArcD2 and OpuA. Synthetic lipids were mixed from
chloroform stocks in the ratio of either 50 mol% DOPE, 12 mol% DOPC, and
38 mol% DOPG or 50 mol% DOPE, 37 mol% DOPC, and 13 mol% DOPG. Lipids
were dried in a rotary vacuum setup (Büchi Labortechnik AG), dissolved in
diethyl ether, dried again and rehydrated in buffer B to a ﬁnal lipid concentration
of 20 mgmL−1. Dissolved lipids, cooled with ice water, were sonicated with a tip
sonicator (Sonics and Materials, Inc.) (15 s on, 45 s off, 70% amplitude, 16 cycles),
frozen-thawed three times, alternating between liquid nitrogen and (a water bath
at) room temperature, and extruded 13 times through a 400 nm pore size poly-
carbonate ﬁlter (Avestin Europe GmbH) to obtain liposomes. Using an established
protocol41, ArcD2 and OpuA were co-reconstituted in preformed liposomes at a
protein to lipid ratio of 1:2:400 (w/w), respectively. The liposomes were ﬁrst diluted
ﬁve times to a ﬁnal concentration of 4 mgmL−1 in buffer B with 25% (v/v) glycerol
[ﬁnal concentration 20% (v/v)] and then destabilized by a stepwise titration with
10% (v/v) Triton X-100, until the membrane was saturated with detergent (Rsat;
ref. 51), after which the membrane proteins were added. The puriﬁed proteins and
destabilized liposomes were mixed for 15 min at 4 °C, after which detergent was
removed by adding SM2 biobeads (600 mg per 20 mg of lipids) in three equal
aliquots with 15 min incubation in between each addition. After the third addition,
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the mixture was incubated overnight, which was followed by one additional
addition (200 mg per 20 mg of lipids) of SM2 biobeads and incubation for 1 h.
Finally, the proteoliposomes were collected by centrifugation (2 h for 38% (w/w)
DOPG lipids or 4 h for 13% (w/w) DOPG lipids, 125,000 × g, 4 °C) and resus-
pended in 200 µL per 20 mg of lipids, yielding a ﬁnal lipid concentration of 100 mg
mL−1. For the 14C-arginine transport assay (see transport assays), reconstitution
was done similarly as above, except that ArcD2 was reconstituted at a protein to
lipid ratio of 2:400 (w/w). In addition, the proteoliposomes were diluted in buffer B
without glycerol and centrifugation was done for 30 min, 325,000 × g, 4 °C.
Vesicles with a radius of 226 nm have 1.8 × 106 lipids per vesicle. Hence, a
protein-to-lipid ratio of 400:1 (w/w) or 2.9 × 104 (mol/mol) for ArcD2 and 200:1
(w/w) or 5.7 × 104 (mol/mol) for OpuA yield 62 molecules of ArcD2 and 31
molecules of OpuA per vesicle.
Encapsulation of the arginine breakdown pathway. Protocol A1: The ArcD2-
and OpuA-containing vesicles used for most studies were composed of 50 mol%
DOPE, 12 mol% DOPC plus 38 mol% DOPG. The proteoliposomes (66 µL, 6.6 mg
of lipid) containing ArcD2 and OpuA were mixed in buffer B with 1 µM ArcA,
2 µM ArcB, 5 µM ArcC1, 5 mM ADP, 5 mM MgSO4, 0.5 mM ornithine and
optionally 1.6–2.9 µM PercevalHR or 100 µM pyranine in a total volume of 200 µL;
the ﬁnal liposome concentration is 33 mg of lipid mL−1. This yields a ﬁnal buffer of
50 mM KPi pH 7.0 plus 25 mM NaCl (carried over with the puriﬁed ArcA, ArcB,
and ArcC1) or 40 mM NaCl when PercevalHR is also included (see Table 2). The
enzymes, metabolites and dyes were encapsulated by ﬁve freeze-thaw cycles in a
0.5 ml Eppendorf tube, alternating between liquid nitrogen and a 10 °C water bath,
with vortexing of the tube before freezing. Next, the vesicles were extruded 13 times
through a 400 nm pore size polycarbonate ﬁlter; the extruder was pre-washed in
buffer A with 0.5 mM ornithine (buffer G). This procedure homogenizes the
vesicles further and makes it likely that necessary components are present in all
layers and compartments. The vesicles with encapsulated pyranine were then
separated from free pyranine by running them over a 22 cm long Sephadex G-75
(Sigma) column in buffer G at 4 °C. To remove the residual external compounds,
the vesicles were diluted to 6 mL in buffer G, collected by centrifugation (20 min,
325,000 × g, 4 °C) and washed with buffer G (6 mL), after which the vesicles were
centrifuged and resuspended in 40 µL per 6.6 mg of lipid, yielding a ﬁnal con-
centration of 165 mg of lipid mL−1. Vesicles were kept on ice before subsequent
measurements. Importantly, the ratio of the components inside the vesicles is very
similar to the ratio in solution prior to encapsulation (Supplementary Fig. 6).
Protocol A2: Like protocol A1 except that the proteoliposomes were mixed with
internal components in 60 mM KCl, yielding a ﬁnal buffer of 15 mM KPi pH 7.0
plus 25 mM NaCl and 40 mM KCl.
Protocol A3: Like protocol A1 except that the vesicles were loaded with 15 mM
ADP plus equimolar concentrations of MgSO4.
Protocol A4: Like protocol A1 except that the vesicles were extruded through a
200 nm pore size polycarbonate ﬁlter.
Protocol A5: Like protocol A1 except that the vesicles were loaded with 10 mM
ATP, 10 mM MgSO4, 24 mM creatine-phosphate, and 2.4 mgmL−1 creatine kinase
in buffer B40.
Protocol A6: Like protocol A1 except that the proteoliposomes containing
ArcD2 and OpuA were ﬁrst diluted in 6 ml of 50 mM NaPi, pH 7.0 (buffer H),
collected by centrifugation (20 min, 325,000 × g, 4 °C) and resuspended in 66 µl of
buffer H. They were then mixed in buffer H with the components mentioned above
and the ArcA, ArcB, and ArcC1 puriﬁed in 50 mM NaPi instead of 50 mM KPi. In
addition, the extruder was pre-washed and vesicles were resuspended in buffer H
with L-ornithine. This encapsulation yields only sodium and no potassium ions
inside the vesicles.
Protocol A7: Like protocol A1 except that the vesicles consisted of 50 mol%
DOPE, 37 mol% DOPC plus 13 mol% DOPG.
Cryo-EM analysis of vesicles. The vesicles with encapsulated enzymes, metabo-
lites (and sensors) were vitriﬁed and imaging was done on a FEI Tecnai T20,
200 keV; Cryo-stage Gatan model 626. Samples were prepared under isosmotic
conditions and images were recorded under low-dose conditions52. Approximate
diameters of the vesicles were measured in ImageJ. The diameters were converted
to internal volume by assuming spherical vesicles, multiplication by abundance and
re-normalization.
Transport assays. Protocol B1: The vesicles with encapsulated enzymes and
metabolites were diluted to a ﬁnal concentration of 1.67 mgmL−1 in buffer A with
250 mM KCl (buffer I). Glycine betaine was added at a ﬁnal concentration of
18 µM, of which 2% (mol/mol) was 14C-radiolabeled. The mixture was incubated
for 30 min at 30 °C. The internal ATP production was then started by addition of
20 mM arginine and samples of 50 µL were taken at given time intervals. Samples
were diluted in 2 mL of ice-cold buffer I and ﬁltered over 0.45 µm pore size cel-
lulose nitrate ﬁlters to stop the transport assay. The ﬁlter was then washed with
another 2 mL of buffer I. Radioactivity on the ﬁlter was quantiﬁed by liquid
scintillation counting using Ultima Gold MV scintillation ﬂuid (PerkinElmer) and
a Tri-Carb 2800TR scintillation counter (PerkinElmer). The pore size of the ﬁlters
is larger than the diameter of the vesicles, but the ﬁlters retain more than 99% of
the vesicles and allow for rapid ﬁltration41.
Protocol B2: The transport of 14C-arginine was measured similarly, except
that proteoliposomes (66 µL, 6.6 mg of lipid) with only ArcD2 in the membrane,
and L-ornithine or L-citrulline (100 µM, 1 mM, or 10 mM) in buffer B in the
vesicle lumen, were used (encapsulation was done by ﬁve freeze-thaw cycles in a
total volume of 200 µL). The proteoliposomes were ﬁrst extruded 13 times
through a 400 nm pore size polycarbonate ﬁlter, then 13 times through a 200 nm
ﬁlter and diluted to 6 mL in buffer B with or without the same concentration of
L-ornithine or L-citrulline as on the inside. Proteoliposomes were collected by
centrifugation (20 min, 225,000 × g, 4 °C) and either washed with buffer B
(6 mL), centrifuged again and resuspended in 30 µL buffer B per 6.6 mg of lipid,
or directly resuspended in buffer B with the appropriate concentration of L-
ornithine or L-citrulline, yielding a ﬁnal concentration of 220 mg of lipid mL−1.
For the transport assay, proteoliposomes were diluted to a ﬁnal concentration of
2.2 mg of lipid mL−1, in buffer B with 10 µM arginine, of which 10% (mol/mol)
was 14C-radiolabeled, and 100 µL samples were taken at given time intervals. To
impose a membrane potential, proteoliposomes in buffer B, were diluted 100-
fold in 50 mM NaPi (ΔΨ=−120 mV), pH 7.0; 48.15 mM NaPi plus 1.85 mM
KPi, pH 7.0 (ΔΨ=−80 mV); or 39.6 mM NaPi plus 10.4 mM KPi, pH 7.0
(ΔΨ=−40 mV), each supplemented with 1 μM of the potassium ionophore
valinomycin.
Internal ATP:ADP ratio measurements with PercevalHR. Calibration: Puriﬁed
PercevalHR and nucleotides (ATP and ADP) were encapsulated in liposomes. The
encapsulation mixture contained liposomes at 7.5 mg of lipids mL−1, 1.6–2.9 µM
PercevalHR, 5 mM of nucleotides in varying ratios, and 5 mM MgSO4 in buffer B.
The samples were frozen-thawed ﬁve times, extruded 13 times through a 400 nm
pore size polycarbonate ﬁlter, centrifuged twice (20 min, 225,000 × g, 4 °C) and
ﬁnally resuspended in buffer B to a concentration of 167 mgmL−1. The liposomes
were diluted in buffer I with 10 µM carbonyl cyanide-4-(triﬂuoromethoxy) phe-
nylhydrazone (FCCP) to a ﬁnal concentration of 3.34 mg lipids mL−1 in 105.250-
QS cuvettes (Hellma Analytics) in a FP-8300 spectroﬂuorometer (Jasco, Inc.) and
incubated for 3 min at 30 °C. The ﬂuorescence spectrum of PercevalHR was
measured by excitation from 400 ± 5 to 510 ± 5 nm, while the emission was
recorded at 550 ± 5 nm. The encapsulated ATP/ADP ratio was plotted against the
ratio of the peaks at 500 and 430 nm. Equation (3) was re-written with n= 1, to
Table 2 Average number of molecules per vesicle
Compound Internal concentration Molecules per vesicle (84 nm radius) Molecules per vesicle (225 nm radius)
Ornithine 0.5 mM 740 14,500
ADP 5mM 7400 144,600
Mg2+ 5mM 7400 144,600
Pyranine 100 µM 150 2900
PercevalHR 2.9 µM 4 83
Phosphate 50mM 73,700 1,446,200
K+ 50mM 73,700 1,446,200
Na+ 25/40mM 36,800/59,000 723,100/1,157,000
Cl− 25/40mM 36,800/59,000 723,100/1,157,000
ATP/ADP ratio of 3 (without GB uptake) 3.75/1.25mM 5500/1800 108,500/36,200
ATP/ADP ratio of 2 (with GB uptake) 3.33/1.67mM 4900/2500 96,400/48,200
Glycine betaine (imported) 50mM 73,700 1,446,200
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By ﬁtting Eq. (7) to the data points (Supplementary Fig. 2d) the following values
were obtained: k= 3.02, start= 0.46, end= 1.30.
Protocol B3: The vesicles with encapsulated enzymes, metabolites and
PercevalHR were diluted in buffer I with 10 µM FCCP to a ﬁnal concentration of
3.34 mg of lipid mL−1 in 105.250-QS cuvettes (Hellma Analytics) in a FP-8300
spectroﬂuorometer (Jasco, Inc.) and incubated for 30 min at 30 °C. To start ATP
production, 5 mM arginine was added, and after 30 min of incubation glycine
betaine (0, 180 µM or 3.6 mM) was added. The ﬂuorescence spectrum of
PercevalHR was measured continuously, as described above. The ATP/ADP
ratio was obtained from the ratio of the peaks at 500 and 430 nm, using Eq. (4).
Representative traces are shown in the ﬁgure panels, but replicate experiments
have been performed multiple times (n); n values are given in the ﬁgure legends.
Internal pH measurements with pyranine. Calibration: 100 µM pyranine was
encapsulated in liposomes at varying pH between 6.0 and 8.0 in 50 mM KPi. The
samples were frozen-thawed ﬁve times, extruded 13 times through a 400 nm pore
size polycarbonate ﬁlter, and run over a 22 cm long Sephadex G-75 (Sigma) col-
umn. The vesicles were collected by centrifugation (20 min, 325,000 × g, 4 °C),
washed once, centrifuged and resuspended to a concentration of 167 mg of lipid
mL−1. The liposomes were diluted in 50 mM KPi at varying pH to a ﬁnal con-
centration of 3.34 mg lipids mL−1 in 105.250-QS cuvettes (Hellma Analytics) in a
FP-8300 spectroﬂuorometer (Jasco, Inc.) and incubated for 3 min at 30 °C. The
ﬂuorescence spectrum of pyranine was measured by excitation from 380 ± 5 to 480
± 5 nm, while the emission was recorded at 512 ± 5 nm. The ﬂuorescence spectrum
of 0.1 µM pyranine in solution at varying pH between 6.0 and 9.0 in 50 mM KPi
was also measured. The data points from encapsulated pyranine in unshocked
vesicles overlapped perfectly with the in-solution data, therefore the pH in solution
was plotted against the ratio of the peaks at 450 and 405 nm and ﬁtted using the
following logistic function:
y ¼ L
1þ ek ´ ðxx0Þ ð8Þ
where L is the curve’s maximum value; k is the logistic growth rate and x0 is the x-
value of the sigmoid’s midpoint. Equation (8) was re-written with the following
parameters: x= pH and y= F450nm/F405nm to obtain the following equation:






By ﬁtting Eq. (8) to the data points in 50 mM KPi (Supplementary Fig. 4b), the
following values were obtained: L= 3.60, k= 2.38, and x0= 7.84.
When vesicles are exposed to an osmotic upshift by the addition of 250 mM
KCl, the internal KPi concentration increases to ~300 mM. The high salt
concentration shifts the calibration of pyranine, and therefore additional
calibration curves were made with pyranine in 300 mM KPi at pH values ranging
from 6.0 and 9.0. This data was ﬁtted to Eq. (8) (Supplementary Fig. 4b), as above,
to obtain the following values: L= 3.70, k= 2.21, and x0= 7.57. The calibration is
also shifted when the vesicles were encapsulated with 15 mM Mg-ADP instead of
5 mM Mg-ADP (see protocol A3). Therefore, we also made calibration curves with
pyranine in 300 mM KPi plus 15 mM Mg-ADP at pH values ranging from 6.0 to
7.5 (with 15 Mg-ADP and 300 mM KPi the salts precipitated above pH 7.5). This
data was ﬁtted to Eq. (8) (Supplementary Fig. 4c) to obtain the following values:
L= 3.22, k= 2.16, and x0= 7.56.
Protocol B4: The vesicles with encapsulated enzymes, metabolites and pyranine
were diluted in buffer I to a ﬁnal concentration of 3.34 mg lipids mL−1 in 105.250-
QS cuvettes (Hellma Analytics) in a FP-8300 spectroﬂuorometer (Jasco, Inc.) and
incubated for 30 min at 30 °C. To start the ATP production, 5 or 20 mM arginine
was added and after 30 min of incubation, glycine betaine was added at a
concentration of 0 or 180 µM. The ﬂuorescence spectrum of pyranine was
measured as indicated above, and the internal pH was obtained from Eq. (9).
Representative traces are shown in the ﬁgure panels, but replicate experiments have
been performed multiple times (n); n values are given in the ﬁgure legends.
External pH measurements with pyranine. Calibration: The ﬂuorescence spec-
trum of pyranine was measured by excitation from 380 ± 5 to 480 ± 5 nm, while the
emission was recorded at 512 ± 5 nm. The ﬂuorescence spectrum of 0.1 µM pyr-
anine in solution at varying pH between 6.0 and 8.5 in 10 mM KPi plus 355 mM
KCl was measured. The pH in solution was plotted against the ratio of the peaks at
450 and 405 nm and ﬁtted using Eq. (8) (Supplementary Fig. 4d), from which the
following values were obtained: L= 3.27, k= 2.23 and x0= 7.48.
Protocol B5: The vesicles with encapsulated enzymes and metabolites were
diluted in 10 mM KPi pH 7.0 plus 355 mM KCl to a ﬁnal concentration of 3.34
mg of lipids mL−1 in 105.250-QS cuvettes (Hellma Analytics) in a FP-8300
spectroﬂuorometer (Jasco, Inc.) and incubated for 30 min at 30 °C. To start the
ATP production, 5 mM arginine was added. The ﬂuorescence spectrum of
pyranine was measured as indicated above, and the internal pH was obtained
from Eq. (9). Representative traces are shown in the ﬁgure panels, but replicate
experiments have been performed multiple times (n); n values are given in the
ﬁgure legends.
Amino acid and ammonia analysis. Protocol B6: The vesicles with encapsulated
enzymes and metabolites were diluted in buffer I, with or without glycine betaine,
to a ﬁnal concentration of 3.34 mg of lipid mL−1 and incubated for 30 min at 30 °C.
The assay was started by addition of 5 mM arginine and samples of 75 µL were
taken at regular time intervals. Vesicles were removed from the samples by cen-
trifugation (20 min, 225,000 × g, 4 °C) to stop the conversion of external amino
acids. Subsequently, 50 µL of supernatant was mixed with 87.5 µL of 1 M boric acid,
pH 9.0 (adjusted with 4M KOH) and kept on ice before derivatization. In total,
37.5 µL of 99.8% methanol and 1.5 µL of 42 mM diethyl ethoxymethylenemalonate
(DEEMM) were added to the samples for derivatization, after which the samples
were incubated for 30 min in a sonication bath at room temperature, followed by
2 h of incubation in a heat block at 70 °C. The protocol for reverse-phase HPLC
was adapted from ref. 53. Amino acid samples were analyzed on a Shimadzu
prominence HPLC system, containing a DGU-20A5R degassing unit, a LC-30AD
solvent delivery unit, a SIL-30AC autosampler, a CTO-20AC column oven, and an
SPD-M20A UV-VIS/Photodiode Array detector. A Shimadzu XR-ODS 3 × 75 mm
C18 column was used to run the binary gradient with a ﬂow rate of 0.9 mLmin−1
and an injection volume of 5 µL. Eluent A was 25 mM acetate, pH 5.8, supple-
mented with 0.02% (w/v) Na-azide. Eluent B was an 8:2 (v/v) mixture of acet-
onitrile and methanol. The gradient was as follows (all percentages are volume-
based): start was at 94% Eluent A and 6% B; 87% A and 13% B at 2 min; 83% A and
17% B at 10 min; 71% A and 29% B at 11 min; 67% A and 33% B at 16 min; 40% A
and 60% B at 16.1–18 min; 94% A and 6% B at 18.1 min toward the end of the
protocol at 20 min. The compounds were identiﬁed based on retention times and
quantiﬁed using the external standard method (Supplementary Fig. 7).
Membrane permeability with stopped-ﬂow ﬂuorescence. Principle of the
method: To determine the permeability of solutes through the vesicle membrane,
two independent and complementary ﬂuorescence-based kinetic assays were used
as described in M. Gabba et al. (manuscript in preparation). The ﬁrst assay reports
volume changes of vesicles by means of calcein self-quenching ﬂuorescence31. The
second assay monitors the pH variation in the vesicle lumen using the ratio-metric
ﬂuorophore pyranine54. Both assays exploit the out-of-equilibrium relaxation
kinetics of the vesicles after the increase of the external osmotic pressure (osmotic
upshift), i.e., the addition of a solute to the vesicle solution. After the osmotic
upshift, the thermodynamic equilibrium is re-established by (i) water efﬂux (to re-
equilibrate the chemical potential of water) and/or (ii) solute inﬂux (to dissipate the
solute concentration gradient). The contribution of the two ﬂuxes to the recovery
kinetics depends on the relative permeability of water and the solute as described in
M. Gabba et al. (manuscript in preparation).
Osmolyte solutions: The 1 M stock solutions of Na-acetate, NH4Cl, and NH4-
acetate were prepared by dissolving the salts into 100 mM KPi buffer; the pH was
adjusted to 7.0 using 4M NaOH. An empirical linear relation between
concentration and osmolality for each solution was determined as described in M.
Gabba et al. (manuscript in preparation). The stock solutions were then diluted to an
osmolality of ca. 300 mosmol kg−1 by mixing with the liposome solution (yielding
95 mM Na-acetate, 110 mM NH4Cl, and 110 mM NH4-acetate).
Liposome preparation: Liposomes were prepared as described under internal
pH measurements with pyranine (see above), with minor adjustments. Calcein was
added to the vesicle solution (2 mg of lipid in buffer A in a total volume of 1 mL) at
a self-quenching concentration of 10 mM and enclosed by three cycles of freezing
and thawing, alternating between liquid nitrogen and a 40 °C water bath. Pyranine
(300 µM pyranine, ﬁnal concentration) was encapsulated similarly. Next, the
liposomes were extruded 13 times through a 200 nm pore size polycarbonate ﬁlter
and run over a 22 cm long Sephadex G-75 (Sigma) column in buffer A. Vesicles
were collected and diluted to a total volume of 12 mL in buffer A. Empty liposomes
for blank correction were prepared using the same procedure without addition of
calcein or pyranine.
Stopped-ﬂow ﬂuorescence measurements: The permeability of the liposomes
for KPi, KCl, Na-acetate, NH4Cl, and NH4-acetate was assessed by monitoring
the quenching of the ﬂuorescence of calcein and by determining the changes in
the internal pH using pyranine as a probe. A stopped-ﬂow apparatus (SX20,
Applied Photophysics Lim., Leatherhead, Surrey, UK) was used to measure
ﬂuorescence intensity kinetics upon imposition of an osmotic upshift to the
liposomes ﬁlled with calcein or pyranine. The osmolyte (ca. 300 mosmol kg−1
after mixing) and the liposome solutions (pre-equilibrated with 250 mM KCl)
were loaded each in two distinct syringes, forced through the mixer (1:1 mixing
ratio and 2 ms dead time) and into the optical cell (20 μl volume and 2 mm path
length). The temperature was set at 20 °C using a water bath. The white light
emitted by a Xenon arc lamp (150W) was passed through a high precision
monochromator and directed to the optical cell via an optical ﬁber. The band
pass of the monochromator was optimized and set to 0.5 nm (for calcein) or
1.4 nm (for pyranine) to prevent ﬂuorophore photobleaching during the
experiment. The ﬂuorophores were excited at 495 nm (for calcein) or at both 405
and 453 nm (for pyranine). The emitted light, collected at 90°, was ﬁltered by a
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Schott long-pass ﬁlter (cut-off wavelength at 515 nm) and detected by a
photomultiplier tube (Hamamatsu R6095) with 10 μs time resolution. The
voltage of the photomultiplier was automatically selected and kept constant
during each set of experiments. The ﬂuorescence intensity kinetics after the
osmotic shock was recorded with logarithmically spaced time points to better
resolve faster processes. For noise reduction, multiple acquisitions (three for
slow kinetics and nine for fast kinetics) were performed for each experimental
condition. Complete stopped-ﬂow settings and acquired data processing are
described in M. Gabba et al. (manuscript in preparation).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data is available in the main text or supplementary materials. All data and materials
used in the analysis are available upon request to the lead author.
Code availability
All code used in the analysis is available upon reasonable request.
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